Importantly, these alterations were not due to the reduced food intake and were partially counteracted by the anti-IL-6 treatment, suggesting that, as for the gut barrier function, cancer cells and associated increased IL-6 levels contribute to the gut microbial dysbiosis. This evidence concerns the gene IL6 and cancer.